Patients' Attitudes and Perceptions of Implantable Cardioverter-Defibrillators: Potential Barriers to Appropriate Primary Prophylaxis

被引:28
|
作者
Yuhas, Jennifer
Mattocks, Kristin
Gravelin, Laura [2 ]
Remetz, Michael
Foley, John
Fazio, Richard [3 ]
Lampert, Rachel [1 ]
机构
[1] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA
[2] Brown Univ, Sch Med, Providence, RI 02912 USA
[3] Eastern Connecticut Cardiol, Waterford, CT USA
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 2012年 / 35卷 / 10期
关键词
implantable cardioverter defibrillator; primary prevention; patient preferences; QUALITY-OF-LIFE; DECISION-MAKING; HEART-FAILURE; GUIDELINES; KNOWLEDGE; DISTRESS; DEVICES; RECALL; SEX;
D O I
10.1111/j.1540-8159.2012.03497.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Primary prophylaxis with implantable cardioverter-defibrillators (ICDs) improves mortality in patients at risk for sudden cardiac death (SCD). However, ICDs are highly underutilized. We explored patients attitudes and perceptions of ICDs to better understand potential patient-related barriers to appropriate utilization. Methods: Records of patients visiting three outpatient cardiology clinics (June 2009January 2010) were reviewed and 133 with ejection fractions =35% and without an ICD were identified. Seventy-two met criteria for ICD placement. Twenty-five consented and were interviewed by telephone using a semistructured open-ended interview guide. Twelve individuals had accepted ICD referral, and 13 had declined. We analyzed transcripts of ICD refusers and acceptors using the constant comparative method of grounded theory. Results: Five major themes emerged: (1) Patients who refused ICD referral demonstrated a lack of insight into their own risk potential. (2) Many patients who accepted ICD referral perceived that this was strongly recommended by their physicians, although many patients refusing did not. (3) Concerns over recall, malfunction, and surgical risk were common in both. (4) Many patients demonstrated inaccurate perceptions of ICD-related risks and lifestyle changes. Acceptors often reported these perceptions being addressed by their physician. (5) Feelings regarding invasive life-prolonging interventions played an important role in ICD referral refusal for some individuals. Conclusions: Refusal of ICD is common among primary prevention candidates. Common themes in the decision-making process include insight into personal risk of SCD, and perceived strength of the physician recommendation. Providers may want to consider assessment of patients individual understanding and perceptions when discussing ICD prophylaxis. (PACE 2012; 35:11791187)
引用
收藏
页码:1179 / 1187
页数:9
相关论文
共 50 条
  • [1] Predictors of appropriate interventions and mortality in patients with implantable cardioverter-defibrillators
    Winkler, Aleksandra
    Jagus-Jamiola, Agnieszka
    Uzieblo-Zyczkowska, Beata
    Orski, Zbigniew
    Krzyzanowski, Krystian
    Smalc-Stasiak, Magdalena
    Kiliszek, Marek
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2019, 129 (10): : 667 - 672
  • [2] Indications and Outcome of Implantable Cardioverter-Defibrillators for Primary and Secondary Prophylaxis in Patients with Noncompaction Cardiomyopathy
    Caliskan, Kadir
    Szili-Torok, Tamas
    Theuns, Dominic A. M. J.
    Kardos, Attila
    Geleijnse, Marcel L.
    Balk, Aggie H. M. M.
    Van Domburg, Ron T.
    Jordaens, Luc
    Simoons, Maarten L.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2011, 22 (08) : 898 - 904
  • [3] Physicians' knowledge and attitudes regarding implantable cardioverter-defibrillators
    Sherazi, Saadia
    Zareba, Wojciech
    Daubert, James P.
    McNitt, Scott
    Shah, Abrar H.
    Aktas, Mehmet K.
    Block, Robert C.
    CARDIOLOGY JOURNAL, 2010, 17 (03) : 267 - 273
  • [4] Primary Prevention Implantable Cardioverter-Defibrillators in Older Racial and Ethnic Minority Patients
    Pokorney, Sean D.
    Hellkamp, Anne S.
    Yancy, Clyde W.
    Curtis, Lesley H.
    Hammill, Stephen C.
    Peterson, Eric D.
    Masoudi, Frederick A.
    Bhatt, Deepak L.
    Al-Khalidi, Hussein R.
    Heidenreich, Paul A.
    Anstrom, Kevin J.
    Fonarow, Gregg C.
    Al-Khatib, Sana M.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2015, 8 (01) : 145 - U215
  • [5] Primary Prevention Implantable Cardioverter-Defibrillators and Survival in Older Women
    Zeitler, Emily P.
    Hellkamp, Anne S.
    Fonarow, Gregg C.
    Hammill, Stephen C.
    Curtis, Lesley H.
    Hernandez, Adrian F.
    Al-Khalidi, Hussein R.
    Curtis, Jeptha P.
    Heidenreich, Paul A.
    Anstrom, Kevin J.
    Peterson, Eric D.
    Mark, Daniel B.
    Hammill, Bradley G.
    Sanders, Gillian D.
    Al-Khatib, Sana M.
    JACC-HEART FAILURE, 2015, 3 (02) : 159 - 167
  • [6] Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Cardiomyopathy
    Daubert, James P.
    Barnett, Adam S.
    JACC-HEART FAILURE, 2019, 7 (08) : 725 - 727
  • [7] Fragmented QRS and arrhythmic events in patients with implantable cardioverter-defibrillators
    Kucharz, Anna
    Kulakowski, Piotr
    KARDIOLOGIA POLSKA, 2020, 78 (11) : 1107 - 1114
  • [8] Implantable Cardioverter-Defibrillators
    Aronow, Wilbert S.
    AMERICAN JOURNAL OF THERAPEUTICS, 2010, 17 (06) : E208 - E220
  • [9] Electrical Storms in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention
    Escande, William
    Marijon, Eloi
    Defaye, Pascal
    Piot, Olivier
    Leclercq, Christophe
    Sadoul, Nicolas
    Deharo, Jean-Claude
    Empana, Jean-Philippe
    Boveda, Serge
    Klug, Didier
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (11) : 1248 - 1250
  • [10] Potential proarrhythmic effects of implantable cardioverter-defibrillators
    Duru, F
    Candinas, R
    CLINICAL CARDIOLOGY, 1999, 22 (02) : 139 - 146